Collaborative Nature Communications study with The University of Queensland, Yale School of Medicine, and Nucleai examines how tumor cell positioning and glucose use predict which NSCLC patients ...

The study analyzed 2,799 T–DXd–treated breast cancer patients and found that WTS identified ERBB2 (HER2) and ABCC1 as the strongest transcriptomic predictors of T–DXd–specific overall survival. Higher ...

Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare diseaseALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic ...

Parker Foot and Ankle, led by foot and ankle specialist Robert Parker, DPM, FACFAS, FAENS, in collaboration with Regenative ...

The Union Budget 2026 lays the foundation for realising a long-aspired commuter dream — reducing the length of railway ...

While the latest UK Government report into animal testing was keen to highlight a (very slight) decrease from 2.67 million ...

Enterprise architecture is intended to guide long-term decision-making, reduce risk, and align technology with business priorities, yet many EA practices struggle to move beyond conceptual influence.

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic tools for optimizing cancer treatment. By leveraging genomic data, advanced ...

As the countdown to Union Budget 2026 begins, income tax relief has once again emerged as the biggest expectation for India’s ...

Detailed price information for Acrivon Therapeutics Inc (ACRV-Q) from The Globe and Mail including charting and trades.

Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global AI medical ...

Union Budget 2026 drew mixed reactions from industry leaders, who welcomed the growth and capex push while stressing the need for execution clarity, long-term policy support and reform follow-through ...